Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Prognostic and predictive biomarkers in renal cell carcinoma Vickers MM; Heng DYTarget Oncol 2010[Jun]; 5 (2): 85-94With the recent advances in targeted therapies, biomarkers in renal cell carcinoma (RCC) continue to be developed. Historically, information regarding prognosis has come from clinicopathologic variables, however in recent years much research has focused on the molecular basis of renal cell cancer. The discovery of reliable biomarkers in RCC could have an important impact on diagnosis, prognosis, and prediction of therapeutic benefit. To date, most biomarker research has centered on byproducts of the von Hippel-Lindau (VHL) pathway including VHL mutations, vascular endothelial growth factor (ligands and receptors), hypoxia-inducible factor, and carbonic anhydrase IX. This review examines these potential biomarkers, biomarker prognostic models, and molecular expression profiles in the field of renal cell carcinoma.|Antigens, Neoplasm/metabolism[MESH]|Biomarkers, Tumor/*metabolism[MESH]|Carbonic Anhydrase IX[MESH]|Carbonic Anhydrases/metabolism[MESH]|Carcinoma, Renal Cell/*diagnosis/genetics/metabolism/pathology[MESH]|Humans[MESH]|Hypoxia-Inducible Factor 1/metabolism[MESH]|Mutation/genetics[MESH]|Pathology, Molecular/methods[MESH]|Prognosis[MESH]|Vascular Endothelial Growth Factor A/metabolism[MESH]|Von Hippel-Lindau Tumor Suppressor Protein/genetics/*metabolism[MESH] |
